Navigation Links
Eczema Non-Profit Seeks To Shine New Light On Overlooked Condition
Date:7/1/2012

Indian Harbour Beach, Florida (PRWEB) July 01, 2012

ITSAN, a non-profit charity, is on a mission to combat the global health crisis that is Topical Steroid Addiction. The organization’s main effort is to reach Eczema patients with information about the correlation between Topical Steroids and worsening Eczema. Topical Steroids are the main medication used to treat Eczema.

“In 30 years of practice I have seen over 2,000 patients who initially had Eczema, either in youth, teen years or early adulthood. Each patient started off using Cortisone Creams. When the initial dose and potency no longer worked they were prescribed a higher potency with more frequent usage. In addition often pills and injections of cortisone were given,” recounts Dr. Rapaport.

“In all cases we decided to stop steroids and lo and behold, in one to three years, they were all cured. However, in each case the patient experienced a painful and debilitating withdrawal. They would swell, ooze, have difficulty functioning in school or work, scratch continually, and couldn’t sleep; we had to support them with other medication and keep them off steroids,” stated Dr. Rapaport.

Kelly Palace, president and Co-Founder of ITSAN, was diagnosed in 2009 with Steroid Induced Eczema caused by her Topical Steroid Addiction. Kelly decided to start a website to chronicle her recovery and alert people of the dangers associated with Topical Steroids. Since starting the site she has had over 100,000 web visits.

“I was critically covered in full body Eczema with no recourse. I was given Corticosteroid after Corticosteroid and told there was nothing else I could do. I was getting worse and worse until I found Dr. Rapaport’s articles; he saved my life,” said ITSAN President Kelly Palace.

Kelly discovered thousands of people like her, over the Internet, suffering the same Eczema like “incurable” symptoms. Whenever they stopped applying Topical Steroids their skin would flare, burn, and turn red. “Once we each discovered the research, which depicted these exact withdrawal symptoms, we knew our cure was in sight,” said Kelly Palace.

ITSAN’s goals include educating Eczema patients about this medical issue. Gaining more recognition amongst the broader medical community about Topical Steroid Addiction. Labeling changes to Topical Steroids to better warn patients, and patient treatment options for a monitored and less painful withdrawal process.

Kelly Palace has high hopes for those who are still suffering. “We hope that if you’re suffering that you get the help and support you need from the ITSAN resources and our global, community support groups.”

To learn more about Dr. Marvin Rapaport and his research on Topical Steroid Addiction, please visit http://itsan.org/research-and-resources.html#Dr._Marvin_Rapaport

About The International Topical Steroid Addiction Network

ITSAN was officially Co-Founded by Dermatologist Dr. Marvin Rapaport, full professor at UCLA Medical Center and the nations leading expert on the subject. Kelly Palace, Co-Founder and president, was one of the 2,000 patients that Dr. Rapaport treated and cured. An online community of over 100 patients with this condition also contributed ideas, money and inspiration to start ITSAN. For more information please visit http://itsan.org

Read the full story at http://www.prweb.com/releases/2012/7/prweb9659853.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Prenatal Exposure to Common Household Chemical Linked to Eczema
2. Prenatal exposure to common household chemical increases risk for childhood eczema, study says
3. Avid Collector Seeks Jimi Hendrix 1968 Electric Factory Philadelphia Concert Poster
4. Electronic data methods research seeks to build a learning health care system
5. Trial seeks to sniff out cancer
6. FDA Seeks to Limit Antibiotics in Animal Feed
7. Lighthouse Worldwide Solutions Now Monitors Air Quality in Hospitals and Operating Rooms
8. Bees shed light on human sweet perception and metabolic disorders
9. DRE Medical Equipment Unveils FX-300+ Surgical Headlight and Light Source
10. Special Needs Spotlight: Former SFMTA Board Member Bruce Oka Receives Treatment with San Francisco Sedation Dentist Dr. David Blende
11. Could Sunlight Lower Your Odds for Pancreatic Cancer?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions ... to Work employee satisfaction survey, earning them second place for Tampa’s Best Places to ... employees. , “This is a great accomplishment for our team,” says RMS Human ...
(Date:4/29/2016)... ... , ... International Dehydrated Foods, Inc. (IDF™) will attend and sponsor Global Food ... by Hilton Hotel in Oak Brook, Illinois. The two-day event is the largest conference ... , At the seminar, IDF™ will offer samples of its Savory Bone Broth ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Society for ... reproductive endocrinologists are required to report in vitro fertilization (IVF) delivery ... to the practice of assisted reproductive technologies in the United States. , ...
(Date:4/29/2016)... ... 29, 2016 , ... Orthodontics Limited, one of the nation’s ... Dr. Middleberg, were asked by Invisalign to present an “Ask the ... titled “Advancing the Biomechanics of Invisalign Clear Aligners,” Dr. Gemmi and Dr. Middleberg ...
(Date:4/28/2016)... ... April 28, 2016 , ... ProText Layouts is a set of ... X . With ProText Layouts, video editors can create an energetic typography video ... and scale of texts. Creating text-based videos have never been easier. , ProText ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016   Acsis , a leading provider of ... market research and advisory firm IDC has named it ... Worldwide Pharmaceutical Track and Trace Software 2016 Vendor Assessment ... assessment of the capabilities and business strategies of 10 ... Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/28/2016)... , April 28, 2016 ... development of innovative peptide and gene-based immunotherapeutics and vaccines for ... will be presenting at the 3rd Annual Growth Capital ... 5 th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... am on Wednesday, May 4 th by Dr. ...
(Date:4/27/2016)... April 27, 2016  Hologic, Inc. (Nasdaq: ... results for the fiscal second quarter ended March ... of $0.24 increased 41.2%, and non-GAAP diluted EPS ... increased 5.8% on a reported basis, and 6.3% ... "We posted another good quarter, highlighted by 14.6% ...
Breaking Medicine Technology: